Diabetes and infection: Is there a link? - A mini-review

Gerontology

Volumn 59, Issue 2, 2013, Pages 99-104

  Knapp, Sylvia ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Diabetes; Hyperglycemia; Infection; Neutrophil function

Indexed keywords

GLUCOSE; INSULIN; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR;

ANTIBODY RESPONSE; CELLULAR IMMUNITY; DIABETES MELLITUS; DIABETIC PATIENT; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERINSULINEMIA; IN VIVO STUDY; INCIDENCE; INFECTION; INFECTION RISK; INFECTION SENSITIVITY; INSULIN DEPENDENT DIABETES MELLITUS; MORTALITY; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; DISEASE ASSOCIATION; IMMUNE RESPONSE; PATHOGENESIS; RISK FACTOR;

DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; INFECTION;

EID: 84874779305     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000345107     Document Type: Review

References (31)

1. Centers for Disease Control and Prevention: National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta, US Department of Health and Human Services, Centers for Disease Control and Prevention, 2011.
2. Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH, Mukamal KJ, Gillum RF, Holme I, Njolstad I, Fletcher A, Nilsson P, Lewington S, Collins R, Gudnason V, Thompson SG, Sattar N, Selvin E, Hu FB, Danesh J: Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011; 364: 829-841.
3. Bertoni AG, Saydah S, Brancati FL: Diabetes and the risk of infection-related mortality in the U.S. Diabetes Care 2001; 24: 1044-1049.
4. Yende S, van der Poll T, Lee M, Huang DT, Newman AB, Kong L, Kellum JA, Harris TB, Bauer D, Satterfield S, Angus DC: The influence of pre-existing diabetes mellitus on the host immune response and outcome of pneumonia: analysis of two multicentre cohort studies. Thorax 2010; 65: 870-877.
5. Kaplan V, Angus DC, Griffin MF, Clermont G, Scott Watson R, Linde-Zwirble WT: Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med 2002; 165: 766-772.
6. Stegenga ME, Vincent JL, Vail GM, Xie J, Haney DJ, Williams MD, Bernard GR, van der Poll T: Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis. Crit Care Med 2010; 38: 539-545.
7. Shah BR, Hux JE: Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003; 26: 510-513.
8. Muller LM, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AI, Rutten GE: Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 2005; 41: 281-288.
9. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW: Infections in patients with diabetes mellitus. N Engl J Med 1999; 341: 1906-1912.
10. Marrie TJ: Bacteraemic pneumococcal pneumonia: a continuously evolving disease. J Infect 1992; 24: 247-255.
11. Lin SH, Lai CC, Tan CK, Liao WH, Hsueh PR: Outcomes of hospitalized patients with bacteraemic and non-bacteraemic community- acquired pneumonia caused by Streptococcus pneumoniae. Epidemiol Infect 2011; 139: 1307-1316.
12. Bordon J, Peyrani P, Brock GN, Blasi F, Rello J, File T, Ramirez J: The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community- Acquired Pneumonia Organization (CAPO) International Cohort Study. Chest 2008; 133: 618-624.
13. Eibl N, Spatz M, Fischer GF, Mayr WR, Samstag A, Wolf HM, Schernthaner G, Eibl MM: Impaired primary immune response in type- 1 diabetes: results from a controlled vaccination study. Clin Immunol 2002; 103: 249-259.
14. Pozzilli P, Gale EA, Visalli N, Baroni M, Crovari P, Frighi V, Cavallo MG, Andreani D: The immune response to influenza vaccination in diabetic patients. Diabetologia 1986; 29: 850-854.
15. Morigi M, Angioletti S, Imberti B, Donadelli R, Micheletti G, Figliuzzi M, Remuzzi A, Zoja C, Remuzzi G: Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF- - B-dependent fashion. J Clin Invest 1998; 101: 1905-1915.
16. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B: Impaired leucocyte functions in diabetic patients. Diabet Med 1997; 14: 29-34.
17. Chang F-Y, Shaio M-F: Respiratory burst activity of monocytes from patients with noninsulin- dependent diabetes mellitus. Diabetes Res Clin Pract 1995; 29: 121-127.
18. Sunahara KK, Martins JO: Alveolar macrophages in diabetes: friends or foes? J Leukoc Biol 2012; 91: 871-876.
19. Mo Y, Wan R, Wang J, Chien S, Tollerud DJ, Zhang Q: Diabetes is associated with increased sensitivity of alveolar macrophages to urban particulate matter exposure. Toxicology 2009; 262: 130-137.
20. Vallerskog T, Martens GW, Kornfeld H: Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis. J Immunol 2010; 184: 6275-6282.
21. Park S, Rich J, Hanses F, Lee JC: Defects in innate immunity predispose C57BL/6JLeprdb/ Leprdb mice to infection by Staphylococcus aureus. Infect Immun 2009; 77: 1008-1014.
22. Hodgson KA, Morris JL, Feterl ML, Govan BL, Ketheesan N: Altered macrophage function is associated with severe Burkholderia pseudomallei infection in a murine model of type 2 diabetes. Microbes Infect 2011; 13: 1177-1184.
23. Lemos MP, Rhee KY, McKinney JD: Expression of the leptin receptor outside of bone marrow-derived cells regulates tuberculosis control and lung macrophage MHC expression. J Immunol 2011; 187: 3776-3784.
24. Walrand S, Guillet C, Boirie Y, Vasson MP: Insulin differentially regulates monocyte and polymorphonuclear neutrophil functions in healthy young and elderly humans. J Clin Endocrinol Metab 2006; 91: 2738-2748.
25. Kirwan JP, Krishnan RK, Weaver JA, Del Aguila LF, Evans WJ: Human aging is associated with altered TNF-alpha production during hyperglycemia and hyperinsulinemia. Am J Physiol 2001; 281:E1137- E1143.
26. Stegenga ME, van der Crabben SN, Dessing MC, Pater JM, van den Pangaart PS, de Vos AF, Tanck MW, Roos D, Sauerwein HP, van der Poll T: Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans. Diabet Med 2008; 25: 157-164.
27. Cohen G, Ilic D, Raupachova J, Horl WH: Resistin inhibits essential functions of polymorphonuclear leukocytes. J Immunol 2008; 181: 3761-3768.
28. Mancuso P, Gottschalk A, Phare SM, Peters- Golden M, Lukacs NW, Huffnagle GB: Leptin-deficient mice exhibit impaired host defense in gram-negative pneumonia. J Immunol 2002; 168: 4018-4024.
29. Wieland CW, Stegenga ME, Florquin S, Fantuzzi G, van der Poll T: Leptin and host defense against Gram-positive and Gram-negative pneumonia in mice. Shock 2006; 25: 414-419.
30. Stegenga ME, van der Crabben SN, Blumer RM, Levi M, Meijers JC, Serlie MJ, Tanck MW, Sauerwein HP, van der Poll T: Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood 2008; 112: 82-89.
31. Lepper PM, Ott S, Nuesch E, von Eynatten M, Schumann C, Pletz MW, Mealing NM, Welte T, Bauer TT, Suttorp N, Juni P, Bals R, Rohde G: Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study. BMJ 2012; 344:e3397.